Loading resource…

American College of Cardiology
Heart failure with mildly reduced ejection fraction (HFmrEF) is increasingly recognized as a distinct yet heterogeneous phenotype within the heart failure spectrum. Advances in diagnostic tools, including strain imaging and molecular imaging, have contributed to a deeper understanding of HFmrEF's complex pathophysiology. Although high-quality clinical evidence remains limited, recent studies have offered promising therapeutic options. Future management strategies should focus on precision medicine and individualized care to optimize patient outcomes.
No account needed